The Perfect Life!

Already an hour after publishing my last post on the effects of a Mediterranean diet on cardiovascular risk on May 26, 2013, one of my former patients who follows my blog carefully sent me an email with the subject “The Perfect Life”, which I – with his consent – would like to release here:

“Andreas is born. As a child at the age of 3 he already learns an instrument, because recent studies have shown that it is raising IQ. Continue reading

Mediterranean Diet Reduces Cardiovascular Risk

Today’s post has nothing directly to do with mental health issues. However, since the cardiovascular fitness significantly affects the risk for psychiatric disorders – especially dementia -, I would like to report today on a very interesting study published in the New England Journal of Medicine on April 4, 2013, in which the influence of a Mediterranean diet on cardiovascular risk was studied (Estruch et al., N Engl J Med 2013, 368: 1279-1290). Continue reading

Depression in Pregnancy: To Treat or not to Treat?

The occurrence of depression in pregnancy poses a particular therapeutic challenge, since the benefits and risks of a pharmacotherapy have to be particularly carefully weighed against each other. If the indication is checked for an antidepressant pharmacotherapy during pregnancy, one tends to forget that not only the drug therapy is associated with risks, but also a potential non-treatment. Continue reading

QTc Prolongation with Citalopram: Is the Warning still Justified?

On August 24th, 2011, the American FDA had issued a safety warning, in which they pointed out that there is a risk of prolongation of the QT interval associated with the use of citalopram. Since the risk would increase dose-dependently, it was recommended not to administer citalopram daily doses above 40 mg. In patients aged > 65 years, the dose should not exceed 20 mg daily. On March 28th, 2012, the FDA published an update to this safety warning. Continue reading